SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 233,973 Value ($000) $3,599 Avg Close $13.09 Range $8.59 - $17.24

Q2 2025

Shares 232,123 Value ($000) $2,175 Avg Close $11.01 Range $8.58 - $14.24

Q4 2024

Shares 12,624 Value ($000) $167 Avg Close $17.11 Range $12.40 - $22.50

Q3 2024

Shares 989,904 Value ($000) $19,056 Avg Close $20.66 Range $17.34 - $25.07

Q2 2024

Shares 1,830,427 Value ($000) $37,579 Avg Close $20.93 Range $18.65 - $24.38

Q1 2024

Shares 2,032,059 Value ($000) $48,363 Avg Close $22.30 Range $19.58 - $25.34

Q4 2023

Shares 2,101,911 Value ($000) $45,422 Avg Close $15.37 Range $11.21 - $21.84

Q3 2023

Shares 603,962 Value ($000) $8,770 Avg Close $18.92 Range $12.85 - $23.55

Q2 2022

Shares 11,637 Value ($000) $224 Avg Close $16.66 Range $13.27 - $19.91

Q1 2022

Shares 109,618 Value ($000) $1,906 Avg Close $16.84 Range $14.56 - $22.27

Q4 2021

Shares 11,637 Value ($000) $254 Avg Close $18.48 Range $14.76 - $22.71

Q3 2021

Shares 11,637 Value ($000) $222 Avg Close $16.66 Range $13.58 - $20.32

Q4 2020

Shares 191,788 Value ($000) $4,265 Avg Close $20.74 Range $13.92 - $27.85

Q1 2020

Shares 53,265 Value ($000) $584 Avg Close $9.38 Range $6.32 - $12.27

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	233,973	$3,599	$13.09	$8.59 - $17.24
Q2 2025	232,123	$2,175	$11.01	$8.58 - $14.24
Q4 2024	12,624	$167	$17.11	$12.40 - $22.50
Q3 2024	989,904	$19,056	$20.66	$17.34 - $25.07
Q2 2024	1,830,427	$37,579	$20.93	$18.65 - $24.38
Q1 2024	2,032,059	$48,363	$22.30	$19.58 - $25.34
Q4 2023	2,101,911	$45,422	$15.37	$11.21 - $21.84
Q3 2023	603,962	$8,770	$18.92	$12.85 - $23.55
Q2 2022	11,637	$224	$16.66	$13.27 - $19.91
Q1 2022	109,618	$1,906	$16.84	$14.56 - $22.27
Q4 2021	11,637	$254	$18.48	$14.76 - $22.71
Q3 2021	11,637	$222	$16.66	$13.58 - $20.32
Q4 2020	191,788	$4,265	$20.74	$13.92 - $27.85
Q1 2020	53,265	$584	$9.38	$6.32 - $12.27